ENDRA Life Sciences annual gross margin
2016
2017
2018
ENDRA Life Sciences's gross margin was 100.00% for fiscal 2018.
View full ENDRA Life Sciences company overview| Fiscal year | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| 2018 | 2018-12-31 | 100.00% | +49.14 pp |
| 2017 | 2017-12-31 | 50.86% | −3.39 pp |
| 2016 | 2016-12-31 | 54.25% | — |
| Fiscal quarter | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| Q1 2018 | 2018-03-31 | 100.00% | — |
| Q4 2017 | 2017-12-31 | 54.96% | — |
| Q3 2017 | 2017-09-30 | 58.79% | — |
| Q2 2017 | 2017-06-30 | 10.98% | — |
Across the available reported history, ENDRA Life Sciences's gross margin increased from 50.86% to 100.00%, a change of +49.14 percentage points. The latest reported quarter, Q1 2018, shows 100.00%.
Gross margin measures the percentage of revenue remaining after the direct costs of producing goods or services. It helps show how efficiently a company turns sales into gross profit before operating expenses.
TickerStat calculates gross margin as SEC-reported gross profit divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review ENDRA Life Sciences filings at SEC.gov ↗